今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

小米空调强势进军京东平台，销量收入双双攀升，有望超越小米电视

北京，2024年6月18日 - 小米空调近日在京东平台取得亮眼成绩，销量和收入均跻身前三，展现出强劲的发展势头。这一成绩不仅标志着小米空调在国内空调市场的地位进一步巩固，也预示着小米空调未来将取得更大的突破。

强势增长，销量跃居前三

据京东平台数据显示，自618大促以来，小米空调凭借卓越的产品性能和实惠的价格，在众多品牌中脱颖而出。截至6月3日晚，小米空调的累计销量紧随美的和格力之后，位列第三，超过华凌、海尔、奥克斯等知名品牌。

细分市场表现强劲，彰显品牌实力

在新风空调和空调大挂机这两个细分市场中，小米空调更是展现出强大的竞争力。在两大细分市场的累计销量前十名中，小米空调均占据三席，与美的、格力等老牌巨头分庭抗礼。这充分体现了小米空调在产品创新和用户体验方面的强大实力。

稳健发展，市场份额持续扩大

回顾过去几年，小米空调一直保持着高速增长态势。从2021年的200万台出货量到2022年的300万台再到2023年的440万台，小米空调的出货量逐年攀升，市场份额不断扩大。特别是在2023年第二季度，小米空调迎来了爆发式增长，出货量同比大涨超90%，助推了市场领先地位的巩固。

未来可期，有望成为线上市场第三

展望未来，小米空调的发展前景更为广阔。根据市场预测，2024年小米空调的出货量有望超过700万台，零售份额将达到约11.5%。同时，在市场份额方面，小米空调也有望成为线上市场的第三名，并接近线下市场第三名的位置。

小米空调的成功，离不开其对产品创新的坚持和对用户需求的敏锐洞察。 小米空调始终致力于为用户提供高品质、高性价比的产品和服务，并不断完善用户体验。未来，小米空调将继续深耕空调市场，为用户带来更多惊喜。

附：

• 小米空调京东平台销量链接：https://so.m.jd.com/pinpai/870-18374.html
• 小米空调官方网站：https://www.mi.com/us/